The administration stated that the pharmaceutical company would have sold many of its products to the government's insurance program for low -income Americans at prices that align with those in Europe.
The administration stated that the pharmaceutical company would have sold many of its products to the government's insurance program for low -income Americans at prices that align with those in Europe.
